Dr. Daniel D. Vaz, MD

Dr. Vaz practices at Fontana Medical Center in Fontana, California, part of Kaiser Permanente.

Dr. Vaz's NPI, 1356950190, was assigned on July 28, 2020. Dr. Vaz holds Wisconsin license 76380-20.

Dr. Vaz's primary practice is Fontana Medical Center, at 9961 Sierra Ave, Fontana, CA 92335 in San Bernardino County. The practice phone is (909) 427-5000.

Dr. Vaz's primary practice is Fontana Medical Center in Fontana, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Vaz to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaz practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Vaz's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Vaz is licensed in Wisconsin.

CMS data shows 167 Medicare services from Dr. Vaz across 6 procedure codes in 2024, for 89 Medicare patients. Medicare paid $10,602 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Dr. Vaz in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaz's median patient age at 50, with 48% women.

In 2024, Dr. Vaz wrote 768 Medicare Part D claims for 231 patients. 89% of them were for generic drugs. CMS names the drug for 417 of them, across 19 drugs with 11 or more claims each, at $3,898 in total drug cost. In 2023, CMS named 345 claims across 16 drugs.

Dr. Vaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaz as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Vaz from 5 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $21.